We are live on ! Find out more
WC

Walthausen & Co Portfolio holdings

AUM $120M
1-Year Est. Return 2.66%
This Fund
S&P 500
This Quarter Est. Return
+9.34%
1 Year Est. Return
-2.66%
3 Year Est. Return
+63.27%
5 Year Est. Return
10 Year Est. Return
AUM
$1.07B
AUM Growth
+$49.4M
Cap. Flow
-$24.8M
Cap. Flow %
-2.31%
Top 10 Hldgs %
18.99%
Holding
129
New
12
Increased
27
Reduced
63
Closed
15

Sector Composition

Rank Sector Weight
1 Industrials 27.24%
2 Financials 23.42%
3 Consumer Discretionary 13.87%
4 Materials 8.62%
5 Technology 7.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMRI
126
DELISTED
Albany Molecular Research Inc
AMRI
-827,155
Closed -$17.9M
NSU
127
DELISTED
Nevsun Resources Ltd.
NSU
-3,794,514
Closed -$9.14M
HNH
128
DELISTED
Handy & Harman Holdings Ltd.
HNH
-10,018
Closed -$315K

Similar funds

Walthausen & Co's Q3 2017 Portfolio in Review

As of Q3 2017, Walthausen & Co held 129 positions worth $1.07B, up 4.8% from $1.02B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Walthausen & Co's Q3 2017 filing shows 12 new, 27 increased, 63 reduced and 15 closed positions. Its largest new stake was Darling Ingredients: 1,174,615 shares worth $20.6M. The largest sale was Kindred Healthcare, an estimated $25M.

By sector, the portfolio is most concentrated in Industrials at 27% of assets, up from 23% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Walthausen & Co's largest Q3 2017 buy was Darling Ingredients: 1,174,615 shares worth $20.6M.
  • Walthausen & Co added most to Seacor Holdings Inc. in Q3 2017, an estimated $13.9M increase.
  • Walthausen & Co's biggest Q3 2017 reduction was Stoneridge, cutting an estimated $6.82M.
  • Walthausen & Co fully exited Kindred Healthcare in Q3 2017, selling an estimated $25M.
  • Walthausen & Co's ten largest holdings make up 19% of its $1.07B portfolio in Q3 2017.
  • Walthausen & Co opened 12 new positions and closed 15 in Q3 2017.
  • Walthausen & Co's portfolio value rose 4.8% quarter-over-quarter to $1.07B.

Based on Walthausen & Co's 13F filing for Q3 2017, filed 15 Nov 2017.